Global Dermatophytic Onychomycosis Treatment Market Size Study & Forecast, by Product Type (Tablets, Nail Paints), By Route of Administration (Oral, Topical), By Type (Prescribed, Over-the-Counter (OTC)), By Distribution Channel (Hospital Pharmacies, Reta

Global Dermatophytic Onychomycosis Treatment Market Size Study & Forecast, by Product Type (Tablets, Nail Paints), By Route of Administration (Oral, Topical), By Type (Prescribed, Over-the-Counter (OTC)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channels), and Regional Analysis, 2023-2030


Global Dermatophytic Onychomycosis Treatment Market is valued at approximately USD 4.68 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.0% over the forecast period 2023-2030. Dermatophytic onychomycosis, also known as fungal nail infection, is a common condition caused by various types of fungi, primarily dermatophytes. It affects the nails, causing them to become discolored, brittle, and thickened. It constitutes approximately one-third of all fungal infections worldwide, with dermatophytes responsible for around 70%-80% of these cases. This growing prevalence has led to a rising need for medications designed to treat dermatophytic onychomycosis. The growing cases of diabetes, increasing awareness of dermatophytic onychomycosis and its treatment, as well as surging demand for topical treatments are the most prominent factors that are propelling the market demand across the globe.

In addition, the increasing aging population, coupled with the growing prevalence of onychomycosis globally are the leading factors that are accelerating the market growth during the estimated period. According to a 2020 article titled ""High Prevalence of Mixed Infections in Global Onychomycosis,"" the global prevalence of onychomycosis is estimated to be around 10%, with Trichophyton rubrum being the most commonly identified causative organism. Also, as per the NCBI article published in 2022, onychomycosis accounts for roughly half of all nail-related disorders and affects approximately 5.5% of the global population. Furthermore, data from the World Health Organization (WHO) in 2021 indicates that by 2030, approximately one in every six individuals globally will be aged 60 years or older. The number of individuals aged 60 and above is projected to increase from 1 billion in 2020 to 1.4 billion by 2050, effectively doubling the global population of adults aged 60 and over to 2.1 billion by 2050. Moreover, the increasing government support for research and development, as well as the rising introduction of new and innovative treatments presents various lucrative opportunities over the forecast years. However, the high cost of treatment and the side effects of treatment are hindering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Dermatophytic Onychomycosis Treatment Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the growing investment in R&D activities, the introduction of generic versions of oral antifungal medications, along with the growing awareness about the impact of fungal nail infections. Whereas, Asia Pacific is expected to grow at the fastest CAGR over the forecast years. The rising healthcare expenditure, increasing prevalence of onychomycosis, and diabetic patient populations are significantly propelling the market demand across the region.

Major market players included in this report are:
Bausch Health Companies Inc.
Pfizer Inc.
Galderma S.A
GlaxoSmithKline plc
Janssen Pharmaceuticals, Inc.
Cipla Inc.
Kaken Pharmaceuticals Co., Ltd.
Novan, Inc.
Anacor Pharmaceuticals, Inc.
Moberg Pharma AB

Recent Developments in the Market:
 In July 2021, Kaken Pharmaceutical and Almirall S.A. signed a license and distribution agreement to give Almirall the rights to produce and market the topical antifungal efinaconazole in Europe. The objective of this initiative is to increase the company’s geographic reach in Europe.
 In July 2021, Zydus Lifesciences secured approval from the U.S. FDA to market efinaconazole topical solution for the management of onychomycosis. This regulatory milestone bolstered the company's presence and market position in the United States.
Global Dermatophytic Onychomycosis Treatment Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered - Product Type, Route of Administration, Type, Distribution Channel, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Tablets
Nail Paints

By Route of Administration:
Oral
Topical

By Type:
Prescribed
Over-the-Counter (OTC)

By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Channels

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned
Bausch Health Companies Inc.
Pfizer Inc.
Galderma S.A
GlaxoSmithKline plc
Janssen Pharmaceuticals, Inc.
Cipla Inc.
Kaken Pharmaceuticals Co., Ltd.
Novan, Inc.
Anacor Pharmaceuticals, Inc.
Moberg Pharma AB

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.


Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Dermatophytic Onychomycosis Treatment Market, by region, 2020-2030 (USD Billion)
1.2.2. Dermatophytic Onychomycosis Treatment Market, by Product Type, 2020-2030 (USD Billion)
1.2.3. Dermatophytic Onychomycosis Treatment Market, by Route of Administration, 2020-2030 (USD Billion)
1.2.4. Dermatophytic Onychomycosis Treatment Market, by Type, 2020-2030 (USD Billion)
1.2.5. Dermatophytic Onychomycosis Treatment Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Dermatophytic Onychomycosis Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Dermatophytic Onychomycosis Treatment Market Dynamics
3.1. Dermatophytic Onychomycosis Treatment Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing awareness of dermatophytic onychomycosis and its treatment
3.1.1.2. Rising aging population
3.1.1.3. Growing prevalence of onychomycosis
3.1.2. Market Challenges
3.1.2.1. High cost of treatment
3.1.2.2. Side effects of treatment
3.1.3. Market Opportunities
3.1.3.1. Increasing government support for research and development
3.1.3.2. Rising introduction of new and innovative treatments
Chapter 4. Global Dermatophytic Onychomycosis Treatment Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economic
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Dermatophytic Onychomycosis Treatment Market, by Product Type
5.1. Market Snapshot
5.2. Global Dermatophytic Onychomycosis Treatment Market by Product Type, Performance - Potential Analysis
5.3. Global Dermatophytic Onychomycosis Treatment Market Estimates & Forecasts by Product Type 2020-2030 (USD Billion)
5.4. Dermatophytic Onychomycosis Treatment Market, Sub Segment Analysis
5.4.1. Tablets
5.4.2. Nail Paints
Chapter 6. Global Dermatophytic Onychomycosis Treatment Market, by Route of Administration
6.1. Market Snapshot
6.2. Global Dermatophytic Onychomycosis Treatment Market by Route of Administration, Performance - Potential Analysis
6.3. Global Dermatophytic Onychomycosis Treatment Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
6.4. Dermatophytic Onychomycosis Treatment Market, Sub Segment Analysis
6.4.1. Oral
6.4.2. Topical
Chapter 7. Global Dermatophytic Onychomycosis Treatment Market, by Type
7.1. Market Snapshot
7.2. Global Dermatophytic Onychomycosis Treatment Market by Type, Performance - Potential Analysis
7.3. Global Dermatophytic Onychomycosis Treatment Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
7.4. Dermatophytic Onychomycosis Treatment Market, Sub Segment Analysis
7.4.1. Prescribed
7.4.2. Over-the-Counter (OTC)
Chapter 8. Dermatophytic Onychomycosis Treatment Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Dermatophytic Onychomycosis Treatment Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Dermatophytic Onychomycosis Treatment Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
8.4. Dermatophytic Onychomycosis Treatment Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Retail Pharmacies
8.4.3. Online Channels
Chapter 9. Global Dermatophytic Onychomycosis Treatment Market, Regional Analysis
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Dermatophytic Onychomycosis Treatment Market, Regional Market Snapshot
9.4. North America Dermatophytic Onychomycosis Treatment Market
9.4.1. U.S. Dermatophytic Onychomycosis Treatment Market
9.4.1.1. Product Type breakdown estimates & forecasts, 2020-2030
9.4.1.2. Route of Administration breakdown estimates & forecasts, 2020-2030
9.4.1.3. Type breakdown estimates & forecasts, 2020-2030
9.4.1.4. Distribution Channel breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Dermatophytic Onychomycosis Treatment Market
9.5. Europe Dermatophytic Onychomycosis Treatment Market Snapshot
9.5.1. U.K. Dermatophytic Onychomycosis Treatment Market
9.5.2. Germany Dermatophytic Onychomycosis Treatment Market
9.5.3. France Dermatophytic Onychomycosis Treatment Market
9.5.4. Spain Dermatophytic Onychomycosis Treatment Market
9.5.5. Italy Dermatophytic Onychomycosis Treatment Market
9.5.6. Rest of Europe Dermatophytic Onychomycosis Treatment Market
9.6. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Snapshot
9.6.1. China Dermatophytic Onychomycosis Treatment Market
9.6.2. India Dermatophytic Onychomycosis Treatment Market
9.6.3. Japan Dermatophytic Onychomycosis Treatment Market
9.6.4. Australia Dermatophytic Onychomycosis Treatment Market
9.6.5. South Korea Dermatophytic Onychomycosis Treatment Market
9.6.6. Rest of Asia Pacific Dermatophytic Onychomycosis Treatment Market
9.7. Latin America Dermatophytic Onychomycosis Treatment Market Snapshot
9.7.1. Brazil Dermatophytic Onychomycosis Treatment Market
9.7.2. Mexico Dermatophytic Onychomycosis Treatment Market
9.8. Middle East & Africa Dermatophytic Onychomycosis Treatment Market
9.8.1. Saudi Arabia Dermatophytic Onychomycosis Treatment Market
9.8.2. South Africa Dermatophytic Onychomycosis Treatment Market
9.8.3. Rest of Middle East & Africa Dermatophytic Onychomycosis Treatment Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Bausch Health Companies Inc.
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. Pfizer Inc.
10.3.3. Galderma S.A
10.3.4. GlaxoSmithKline plc
10.3.5. Janssen Pharmaceuticals, Inc.
10.3.6. Cipla Inc.
10.3.7. Kaken Pharmaceuticals Co., Ltd.
10.3.8. Novan, Inc.
10.3.9. Anacor Pharmaceuticals, Inc.
10.3.10. Moberg Pharma AB
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
List of Tables
TABLE 1. Global Dermatophytic Onychomycosis Treatment Market, report scope
TABLE 2. Global Dermatophytic Onychomycosis Treatment Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Dermatophytic Onychomycosis Treatment Market estimates & forecasts by Product Type 2020-2030 (USD Billion)
TABLE 4. Global Dermatophytic Onychomycosis Treatment Market estimates & forecasts by Route of Administration 2020-2030 (USD Billion)
TABLE 5. Global Dermatophytic Onychomycosis Treatment Market estimates & forecasts by Type 2020-2030 (USD Billion)
TABLE 6. Global Dermatophytic Onychomycosis Treatment Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
TABLE 7. Global Dermatophytic Onychomycosis Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Dermatophytic Onychomycosis Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Dermatophytic Onychomycosis Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Dermatophytic Onychomycosis Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Dermatophytic Onychomycosis Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Dermatophytic Onychomycosis Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Dermatophytic Onychomycosis Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Dermatophytic Onychomycosis Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Dermatophytic Onychomycosis Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. Global Dermatophytic Onychomycosis Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 18. U.S. Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. U.S. Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 21. Canada Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. Canada Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 24. UK Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. UK Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 27. Germany Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. Germany Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 30. France Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. France Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 33. Italy Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Italy Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 36. Spain Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. Spain Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 39. RoE Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. RoE Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 42. China Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. China Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 45. India Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. India Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 48. Japan Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. Japan Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 51. South Korea Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. South Korea Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 54. Australia Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. Australia Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 57. RoAPAC Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. RoAPAC Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 60. Brazil Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Brazil Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 63. Mexico Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. Mexico Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 66. RoLA Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. RoLA Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. Saudi Arabia Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 69. South Africa Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. RoMEA Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Dermatophytic Onychomycosis Treatment Market
TABLE 72. List of primary sources, used in the study of global Dermatophytic Onychomycosis Treatment Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of Tables and Figures and dummy in nature, final lists may vary in the final deliverable
List of Figures
FIGURE 1. Global Dermatophytic Onychomycosis Treatment Market, research methodology
FIGURE 2. Global Dermatophytic Onychomycosis Treatment Market, Market estimation techniques
FIGURE 3. Global Market size estimates & forecast methods
FIGURE 4. Global Dermatophytic Onychomycosis Treatment Market, key trends 2022
FIGURE 5. Global Dermatophytic Onychomycosis Treatment Market, growth prospects 2023-2030
FIGURE 6. Global Dermatophytic Onychomycosis Treatment Market, porters 5 force model
FIGURE 7. Global Dermatophytic Onychomycosis Treatment Market, pest analysis
FIGURE 8. Global Dermatophytic Onychomycosis Treatment Market, value chain analysis
FIGURE 9. Global Dermatophytic Onychomycosis Treatment Market by segment, 2020 & 2030 (USD Billion)
FIGURE 10. Global Dermatophytic Onychomycosis Treatment Market by segment, 2020 & 2030 (USD Billion)
FIGURE 11. Global Dermatophytic Onychomycosis Treatment Market by segment, 2020 & 2030 (USD Billion)
FIGURE 12. Global Dermatophytic Onychomycosis Treatment Market by segment, 2020 & 2030 (USD Billion)
FIGURE 13. Global Dermatophytic Onychomycosis Treatment Market by segment, 2020 & 2030 (USD Billion)
FIGURE 14. Global Dermatophytic Onychomycosis Treatment Market, regional snapshot 2020 & 2030
FIGURE 15. North America Dermatophytic Onychomycosis Treatment Market 2020 & 2030 (USD Billion)
FIGURE 16. Europe Dermatophytic Onychomycosis Treatment Market 2020 & 2030 (USD Billion)
FIGURE 17. Asia pacific Dermatophytic Onychomycosis Treatment Market 2020 & 2030 (USD Billion)
FIGURE 18. Latin America Dermatophytic Onychomycosis Treatment Market 2020 & 2030 (USD Billion)
FIGURE 19. Middle East & Africa Dermatophytic Onychomycosis Treatment Market 2020 & 2030 (USD Billion)
List of Tables and Figures and dummy in nature, final lists may vary in the final deliverable

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings